FDA Investigator Makini Cobourne Duval, PhD
Makini Cobourne Duval, PhD has conducted inspections on 22 sites in 8 countries as of 22 Mar 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
22
Last Inspection Date:
22 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
India,
New Zealand,
United States of America,
Israel,
Turkey,
Jordan,
Canada,
Spain
FDA Investigators that have inspected at least one site in common with Makini Cobourne Duval, PhD:
Alan P Kurtzberg,
Alanna L Mussawwir Bias,
Alicia M Mozzachio,
Amanda E Lewin, PhD,
Anastasia M Shields,
Anders W Evenson,
Andrea A Branche,
Andrew Le,
Anita Narula, PhD,
Anita R Michael,
Anthony E Keller, RPh,
Atul J Agrawal,
Azza Talaat,
Barbara A Rusin,
Barbara Janine Breithaupt,
Bonita S Chester,
Brandon C Heitmeier,
Camille D Brown,
Chaoying C Ma,
Charles D Brown,
Charles R Cote, RIC,
Christopher D Leach,
Clotia Cabbey Mensah,
Courtney N Long,
Craig A Garmendia,
Cynthia M Goudeau,
Daniel J Lahar,
Daniel L Aisen,
Debra I Love,
Denise L Burosh,
Dipesh K Shah,
Dr. Carmelo Rosa,
Dr. Gopa Biswas, PhD,
Dr. Mark J Seaton, PhD,
Eileen A Liu,
Emest F Bizjak,
Emily J Orban,
Eric M Mueller, PharmD,
Eric S Pittman,
Feiyan Jin,
Gajendiran Mahadevan, PhD,
Gale L Glinecki,
Gavin T Cua,
Gene D Arcy,
Gene R Gunn,
Gulshan R Anand,
Gwyn G Dickinson,
Hasan A Irier, PhD,
Himanshu Gupta, PhD,
Hyojong Kwon, PhD,
Ivis L Negron,
Jacob G Lutz,
Jacob W Reynolds,
Jacqueline Mdiaz Albertini,
Jagan Mohanr Parepally, PhD,
James C Maclaughlin,
James M Mason,
James S Cartwright,
Jane M Kreis,
Janete F Guardia,
Jared P Stevens,
Jasjeet K Sekhon,
Jay V Jariwala,
Jeanne J Thai,
Jeffery A Hangartner,
Jeffrey A Sommers,
Jennifer C Adams,
Joanne M Schlossin,
John A Iwen,
Jonathan R Campos,
Jose A Lopez,
Jose Acruz Gonzalez,
José E Meléndez,
Jose Ohernandez Guzman,
Joseph L Despins, PhD,
Joy P Matthias,
Junho Pak,
Justin A Boyd,
Kara A Scheibner, PhD,
Kari M Johansen,
Katherine Szestypalow,
Kellia N Hicks,
Kenneth H Williams,
Kham Phommachanh,
Kip J Hanks,
Larry K Austin,
Lata C Mathew, PhD,
Li Hongpaul Yeh, PhD,
Liming Zhang,
Linda F Murphy,
Linda R Kuchenthal,
Lori A Gioia,
Lori J Silverstein,
Luis A Dasta,
Maan S Abduldayem,
Margaret M Annes,
Maria V Price,
Massoud Motamed,
Matthew C Watson,
Mei Ou,
Meisha Waters,
Melkamu Getie Kebtie, PhD,
Michael A Charles,
Michael A Taylor,
Michael G Sinkevich,
Michael P Anthony,
Michael Serrano,
Minh D Phan,
Mohsen Rajabi Abhari, FDA,
Muralidhara B Gavini, PhD,
Nancy A Bellamy,
Neal D Singletary, PhD,
Nicholas A Violand,
Nicholas Z Lu,
Nicola M Fenty Stewart,
Nikki S Ramirez,
Pankaj H Amin,
Parul M Patel,
Patrick C Klotzbuecher,
Patty P Kaewussdangkul,
Paul A Bonneau,
Paul L Bellamy,
Peter E Baker,
Peter R Lenahan,
Raymond T Oji,
Richard W Berning,
Rita K Kabaso,
Robert J Doyle,
Robert J Martin,
Robert M Barbosa,
Ronda Rloyd Jones,
Ruben C Ayala, PharmD,
Saleem A Akhtar,
Sam H Haidar, PhD,
Samuel H Chan, PharmD,
Sandra A Hughes,
Sarah E Rhoades,
Sarmistha Sanyal, PhD,
Scott B Laufenberg,
Scott T Ballard,
Seneca D Toms,
Seongeun Cho (Julia), PhD,
Sheri L Stephenson,
Shirley H Isbill,
Sripal R Mada, PhD,
Stanley Au,
Stephen D Brown,
Steven A Gonzales,
Susan M Jackson,
Susanna E Ford,
Susanne M Richardson, MS RAC,
Tamil Arasu, PhD,
Tawny L Colling,
Thomas J Arista,
Thomas W Gordon,
Walden H Lee,
Xiaokuang Lai, PhD,
Xikui Chen (nmi), PhD,
Yiyue Zhang (nmi), PhD,
Young M Choi, PhD,
Yvins Dezan,
Zachary A Bogorad,
Zhaoyang Meng
Makini Cobourne Duval, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2017 | EIR | PPD Development, L.P. - EIR, 2017-03-03 |
March, 2017 | FDA 483 | PPD Development, L.P. - Form 483, 2017-03-03 |
June, 2017 | FDA 483 | Pharmaron (Exton) Lab Services LLC - Form 483, 2017-06-09 |
January, 2018 | FDA 483 | SYNGENE INTERNATIONAL LIMITED - Form 483, 2018-01-26 |
November, 2017 | FDA 483 | Sun Pharmaceutical Medicare Limited - Form 483, 2017-11-17 |
January, 2018 | FDA 483 | Panexcell Clinical Lab PVT. LTD. - Form 483, 2018-01-19 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more